US Edition
PhotoPharmics expands Parkinson’s Trial into further US states - Pharmafile
Summary by pharmafile.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
PhotoPharmics expands Parkinson’s Trial into further US states - Pharmafile
US-based PhotoPharmics, has expanded enrollment in its Light for PD clinical trial beyond its original 300 participants, opening new sites in Illinois, Florida and Arizona. These states were chosen due to their higher populations of retirees and people living with Parkinson’s disease. The Light for PD study is assessing the safety and effectiveness of Celeste, […] The post PhotoPharmics expands Parkinson’s Trial into further US states appeared f…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
